Can-Fite BioPharma (CANF) Minority Interest (2013 - 2017)
Can-Fite BioPharma's (CANF) quarterly Minority Interest came in at $3000.0 in Q3 2017, down 95.45% YoY from $66000.0 in Q3 2016, and down 92.68% on a QoQ basis from $41000.0 in Q2 2017.
Can-Fite BioPharma (CANF) Minority Interest (2013 - 2017) Analysis & Trends
Can-Fite BioPharma (CANF) has 5 years of Minority Interest data on file, last reported at $3000.0 in Q3 2017.
- Quarterly Minority Interest fell 95.45% year-over-year to $3000.0 in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $3000.0 (down 95.45% YoY) and the FY2016 annual result came in at $42000.0, changed N/A from the prior year.
- Minority Interest eased to $3000.0 in Q3 2017, from $41000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $709000.0 in Q3 2013 to a low of $3000.0 in Q3 2017.
- A 5-year average of $288333.3 and a median of $228000.0 in 2015 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2014 — Minority Interest decreased 10.68% — and 2017, when it tumbled 95.45%.
- Tracing CANF's Minority Interest over 5 years: stood at $709000.0 in 2013, then tumbled by 33.71% to $470000.0 in 2014, then tumbled by 51.49% to $228000.0 in 2015, then tumbled by 81.58% to $42000.0 in 2016, then sank by 92.86% to $3000.0 in 2017.
- The last three Minority Interest figures came in at $3000.0 (Q3 2017), $41000.0 (Q2 2017), and $38000.0 (Q1 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Can-Fite BioPharma | 2.78 Mn | -8.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | 41,000.00 |
| Mar 31, 2017 | 38,000.00 |
| Dec 31, 2016 | 42,000.00 |
| Sep 30, 2016 | 66,000.00 |
| Jun 30, 2016 | 91,000.00 |
| Mar 31, 2016 | 133,000.00 |
| Sep 30, 2015 | 228,000.00 |
| Jun 30, 2015 | 321,000.00 |
| Mar 31, 2015 | 327,000.00 |
| Sep 30, 2014 | 470,000.00 |
| Jun 30, 2014 | 569,000.00 |
| Mar 31, 2014 | 650,000.00 |
| Sep 30, 2013 | 709,000.00 |
| Jun 30, 2013 | 637,000.00 |